Medorubicin - CISMeF

Preferred Label : Medorubicin;

NCIt synonyms : (1S,3S)-3-Glycoloyl-1,2,3,4,6,11-Hexahydro-3,5,12-Trihydroxy-6,11-Dioxo-1-Naphthacenyl 3-Amino-2,3,6-Trideoxy-Alpha-L-Lyxo-Hexopyranoside; 4-Demethoxydoxorubicin;

NCIt definition : A demethoxy derivative of doxorubicin with antineoplastic activity.;

UNII : NU158DGH9E;

InChIKey : XVXGYZFARCOVHS-BINOZUKVSA-N;

CAS number : 64314-52-9; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 64314-52-9 alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo G-SRS /a ;

Chemical formula : C26H27NO10;

NSC code : 256438;

Details

Origin ID

C87599;

UMLS CUI

C2981295;

Automatic exact mappings (from CISMeF team)
- 4-demethoxydoxorubicin [MeSH concept]
- 4-demethoxydoxorubicin [MeSH Supplementary Concept]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]
- GDC Terminology [NCIt concept]
- GDC Therapeutic Agent Terminology [NCIt concept]
- GDC Value Terminology [NCIt concept]
- NCIt Antineoplastic Agent Terminology [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients